Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon β
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Urodynamics findings in transverse myelitis patients with lower urinary tract symptoms: Results from a tertiary referral urodynamic center.
'The worm that got away': parainfectious atypical optic neuritis associated with schistosomiasis infection.
Long-term safety of azathioprine therapy in multiple sclerosis.
[Demyelinating process in systematic rheumatoid diseases (review)].
Microglia - performers of the 21st century.
Circulating levels of soluble apoptosis-related molecules in patients with multiple sclerosis.
Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
Implanting glass spinal cord windows in adult mice with experimental autoimmune encephalomyelitis.
Widespread Pressure Pain Hypersensitivity in Patients with Multiple Sclerosis with and Without Pain as Sign of Central Sensitization.
Btn2a2, a T cell immunomodulatory molecule coregulated with MHC class II genes.
Gray matter damage predicts the accumulation of disability 13 years later in MS.
Autoimmune priming tissue attack and chronic inflammation - The three stages of rheumatoid arthritis.
17β-estradiol replacement therapy protects myelin sheaths in the white matter of middle-aged female ovariectomized rats: a stereological study.
Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
Relationship between gait initiation and disability in individuals affected by multiple sclerosis.
Unethical for neurologists not to offer patients with multiple sclerosis chemotherapy with autologous stem cell support.
Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma.
Use and users of complementary and alternative medicine among people with multiple sclerosis in Denmark.
Modulation of TLR3/TLR4 inflammatory signaling by the GABAB receptor agonist baclofen in glia and immune cells: relevance to therapeutic effects in multiple sclerosis.
Human endogenous retrovirus-K contributes to motor neuron disease.
Risk factors for multiple sclerosis and associations with anti-EBV antibody titers.
B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis.
Pages
« first
‹ previous
…
524
525
526
527
528
529
530
531
532
…
next ›
last »